These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 24633463

  • 1. Protective effect of resveratrol derivatives on high-fat diet induced fatty liver by activating AMP-activated protein kinase.
    Choi YJ, Suh HR, Yoon Y, Lee KJ, Kim DG, Kim S, Lee BH.
    Arch Pharm Res; 2014; 37(9):1169-76. PubMed ID: 24633463
    [Abstract] [Full Text] [Related]

  • 2. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
    Seo MS, Kim JH, Kim HJ, Chang KC, Park SW.
    Toxicol Appl Pharmacol; 2015 Apr 15; 284(2):113-24. PubMed ID: 25737164
    [Abstract] [Full Text] [Related]

  • 3. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.
    Lee JH, Baek SY, Jang EJ, Ku SK, Kim KM, Ki SH, Kim CE, Park KI, Kim SC, Kim YW.
    Chem Biol Interact; 2018 Jun 01; 289():68-74. PubMed ID: 29702089
    [Abstract] [Full Text] [Related]

  • 4. S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway.
    Hwang YP, Kim HG, Choi JH, Do MT, Chung YC, Jeong TC, Jeong HG.
    J Nutr Biochem; 2013 Aug 01; 24(8):1469-78. PubMed ID: 23465592
    [Abstract] [Full Text] [Related]

  • 5. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D, Larequi E, Belza I, Astudillo AM, Martínez-Ansó E, Balsinde J, Argemi J, Aragon T, Moreno-Aliaga MJ, Muntane J, Prieto J, Bustos M.
    J Hepatol; 2014 May 01; 60(5):1017-25. PubMed ID: 24362075
    [Abstract] [Full Text] [Related]

  • 6. Magnolia officinalis attenuates free fatty acid-induced lipogenesis via AMPK phosphorylation in hepatocytes.
    Seo MS, Hong SW, Yeon SH, Kim YM, Um KA, Kim JH, Kim HJ, Chang KC, Park SW.
    J Ethnopharmacol; 2014 Nov 18; 157():140-8. PubMed ID: 25261688
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate-activated protein kinase in human HepG2 cells and obese mice.
    Hwang YP, Choi JH, Han EH, Kim HG, Wee JH, Jung KO, Jung KH, Kwon KI, Jeong TC, Chung YC, Jeong HG.
    Nutr Res; 2011 Dec 18; 31(12):896-906. PubMed ID: 22153515
    [Abstract] [Full Text] [Related]

  • 9. Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction.
    Jin SH, Yang JH, Shin BY, Seo K, Shin SM, Cho IJ, Ki SH.
    Toxicol Appl Pharmacol; 2013 Aug 15; 271(1):95-105. PubMed ID: 23651738
    [Abstract] [Full Text] [Related]

  • 10. Effects of Eriobotrya japonica Water Extract on Alcoholic and Nonalcoholic Fatty Liver Impairment.
    Mun J, Park J, Yoon HG, You Y, Choi KC, Lee YH, Kim K, Lee J, Kim OK, Jun W.
    J Med Food; 2019 Dec 15; 22(12):1262-1270. PubMed ID: 31834842
    [Abstract] [Full Text] [Related]

  • 11. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1α axis in db/db mice.
    Kim MY, Lim JH, Youn HH, Hong YA, Yang KS, Park HS, Chung S, Ko SH, Shin SJ, Choi BS, Kim HW, Kim YS, Lee JH, Chang YS, Park CW.
    Diabetologia; 2013 Jan 15; 56(1):204-17. PubMed ID: 23090186
    [Abstract] [Full Text] [Related]

  • 12. 2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed mice.
    Zhang J, Zhang LN, Chen DM, Fu YY, Zhang F, Yang LL, Xia CM, Jiang HW, Tang CL, Xie ZF, Yang F, Li J, Tang J, Li JY.
    Acta Pharmacol Sin; 2015 Apr 15; 36(4):483-96. PubMed ID: 25832429
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.
    Food Chem Toxicol; 2014 Feb 15; 64():94-103. PubMed ID: 24275089
    [Abstract] [Full Text] [Related]

  • 16. Fermented Rhus verniciflua Stokes Extract Exerts an Antihepatic Lipogenic Effect in Oleic-Acid-Induced HepG2 Cells via Upregulation of AMP-Activated Protein Kinase.
    Lee MS, Kim JS, Cho SM, Lee SO, Kim SH, Lee HJ.
    J Agric Food Chem; 2015 Aug 19; 63(32):7270-6. PubMed ID: 26176317
    [Abstract] [Full Text] [Related]

  • 17. Retinoic acid receptor-related orphan receptor α-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis.
    Kim EJ, Yoon YS, Hong S, Son HY, Na TY, Lee MH, Kang HJ, Park J, Cho WJ, Kim SG, Koo SH, Park HG, Lee MO.
    Hepatology; 2012 May 19; 55(5):1379-88. PubMed ID: 22183856
    [Abstract] [Full Text] [Related]

  • 18. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
    Kang OH, Kim SB, Mun SH, Seo YS, Hwang HC, Lee YM, Lee HS, Kang DG, Kwon DY.
    Int J Mol Med; 2015 Mar 19; 35(3):803-9. PubMed ID: 25605057
    [Abstract] [Full Text] [Related]

  • 19. Licochalcone A regulates hepatic lipid metabolism through activation of AMP-activated protein kinase.
    Quan HY, Kim SJ, Kim DY, Jo HK, Kim GW, Chung SH.
    Fitoterapia; 2013 Apr 19; 86():208-16. PubMed ID: 23500383
    [Abstract] [Full Text] [Related]

  • 20. Resveratrol suppresses T0901317-induced hepatic fat accumulation in mice.
    Gao M, Liu D.
    AAPS J; 2013 Jul 19; 15(3):744-52. PubMed ID: 23591747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.